belvarafenib
type II RAF dimer kinase inhibitor oral 450 mg BID, Ph. II in BRAF/RAS cancers demonstrated activity in NRAS-mut. tumors Nature, May 5, 2021 Genentech, CA / Hanmi Pharma, KR
Molecules of the Month - May 2021
Molecules of the Month
- GDC-0077
- belvarafenib
- folate-MS432
- TAK-931
- icenticaftor
- MK-8153
- JNJ-61803534
- M3258
- BMS-753426
- LUT014
- GLPG2938
- RRx-001
- compound 7 (GO/LDHA)
- compound 6 (BTK)